0 Commentaires
0 Parts
6KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
(R)-Duloxetine Market Industry Analysis (2026-2034): Expanding Demand for Chiral APIs and Neuropathic Pain Therapies Drives Pharmaceutical GrowthGlobal (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period. (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...0 Commentaires 0 Parts 222 Vue 0 Aperçu
-
Global Lactulose Concentrate Syrup Market Growth Outlook (2026-2034): Digestive Health Demand, Pharmaceutical Expansion, and Regional Industry AnalysisGlobal Lactulose Concentrate Syrup market demonstrates steady growth, with its valuation reaching USD 152 million in 2023 and projected to expand at a CAGR of 4.10% through 2032, reaching approximately USD 218.22 million. This growth trajectory stems from rising applications in pharmaceuticals and food industries, particularly in regions witnessing increased healthcare expenditure and digestive...0 Commentaires 0 Parts 254 Vue 0 Aperçu
-
"Tablet Coatings Market Trends: How the Industry Will Evolve by 2031"With the rise of personalized medicine, tablet coatings are becoming increasingly important. Tailored tablet coatings that can accommodate specific dosages or delivery mechanisms for individualized treatments are emerging. This trend presents a huge opportunity for companies specializing in custom coatings for unique therapeutic regimens. The Tablet Coatings Market is poised for...0 Commentaires 0 Parts 7KB Vue 0 Aperçu1
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentaires 0 Parts 994 Vue 0 Aperçu
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Competitive Landscape of the Performance Enhancing Drugs MarketGrowing demand for endurance improvement solutions is influencing pharmaceutical development strategies.New drug delivery technologies are enhancing safety and efficacy.Expanding clinical trials are expected to create future growth opportunities. The Performance Enhancing Drugs Market The market is projected to grow at a CAGR of 7.2% from 2025 to 2031, with valuation expected to expand from US$...0 Commentaires 0 Parts 6KB Vue 0 Aperçu
-
Contract Manufacturing Boom Supporting API CDMO Market ExpansionRegulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion. Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...0 Commentaires 0 Parts 7KB Vue 0 Aperçu2
-
Cough and Cold Medicine Market Projected to Grow at 4.3% CAGR Through 2034, Driven by OTC DemandAccording to a new report from Intel Market Research, the global cough and cold medicine market was valued at USD 21.5 billion in 2025 and is projected to reach USD 32.1 billion by 2034, growing at a steady CAGR of 4.3% during the forecast period (2026–2034). This growth stems from rising global incidences of respiratory infections, increasing self-medication practices, and continuous...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Dapoxetine Market Future Trends Shaping Growth and Innovation to 2034The global landscape for dapoxetine is evolving steadily, supported by increasing recognition of men’s health issues and improved access to treatment solutions. Changing patient behavior and growing openness toward addressing sexual wellness concerns are influencing demand patterns across regions. Healthcare providers are also playing a more proactive role in diagnosing and managing...0 Commentaires 0 Parts 815 Vue 0 Aperçu
-
Geriatric Medicines Market Demand Analysis and Future ProspectsRising healthcare expenditure for elderly care is contributing to consistent market growth. Governments and private institutions are investing in aging population management programs. This financial support enhances the adoption of specialized medicines. The geriatric medicines market is witnessing strong and sustained growth as healthcare systems worldwide adapt to the needs of an aging...0 Commentaires 0 Parts 6KB Vue 0 Aperçu
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global DXM and Codeine Syrup Market to Reach USD 2.75 Billion by 2034 Amid Rising Respiratory IllnessesAccording to a new report from Intel Market Research, the global DXM and Codeine Syrup market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a CAGR of 7.2% during the forecast period (2026-2034). This growth is driven by increasing respiratory illness prevalence, rising healthcare expenditure in emerging economies, and expanding...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Potassium Gluconate Market to Reach USD 520 Million by 2034 Driven by Growing Demand for Electrolyte SupplementsAccording to a new report from Intel Market Research, the global Potassium Gluconate market was valued at USD 320 million in 2025 and is projected to reach USD 520 million by 2034, growing at a steady CAGR of 5.3% during the forecast period (2026–2034). This expansion reflects increasing global demand for electrolyte supplements, food fortification applications, and pharmaceutical...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Plus de résultats